Skip to content

Publications CAN/CSA-Z900.1-17

Sorry, no image available for CAN/CSA-Z900.1-17

CAN/CSA-Z900.1-17 - Cells, tissues, and organs for transplantation: General requirements

Publication Year:

  • 2017

Total Pages:

81

Publisher:

  • CSA

Preface

This is the third edition of CAN/CSA-Z900.1, Cells, tissues, and organs for transplantation: General requirements. It supersedes the previous editions published in 2012 and 2003.

This Standard and its subset standards (which contain requirements for specific types of cells, tissues, and organs) are part of a series of management system standards and were developed from the work initiated by Health Canadaís Expert Working Group on Safety of Organs and Tissues for Transplantation. See Annex A. The subset standards include the following:

- CAN/CSA-Z900.2.2, Tissues for transplantation;

- CAN/CSA-Z900.2.3, Perfusable organs for transplantation;

- CAN/CSA-Z900.2.4, Ocular tissues for transplantation; and

- CAN/CSA-Z900.2.5, Lymphohematopoietic cells for transplantation.

CAN/CSA-Z900.2.1, Tissues for assisted reproduction, although a part of the CAN/CSA-Z900 series, is a stand-alone standard and does not refer to the requirements in CAN/CSA-Z900.1.

Major changes to this edition include the following:

- The requirement for SOP review and approvals in Clause 6 has been changed from every year to every two years.

- Guidance on specific emerging diseases and pathogens has been introduced to help ensure users of this Standard refer to the most current information available at any given time.

- Annex E has been updated to include assessment on intranasal cocaine use.

- In Annex E, the deferral period for men having sex with men has been updated from 5 years to 12 months

- Additional clarification regarding the contraindications for HBV and HCV has been provided.

CSA Group gratefully acknowledges that the development of this Standard was made possible, in part, by the financial support of Health Canada.

Scope

1.1
This Standard specifies general requirements related to the safety of human cells, tissues, and organs used for transplantation, and includes quality system requirements. It includes aspects of safety for potential and actual donors and recipients, personnel, and others who might be exposed to or affected by the transplantation of cells, tissues, or organs.

1.2
This Standard applies to establishments and individuals involved in the following activities related to cells, tissues, and organs intended for transplantation:

a) processing;

b) evaluation of the safety of cells, tissues, and organs prior to transplantation;

c) transplantation procedures;

d) recordkeeping;

e) error, accident, and adverse reaction reporting;

f) distribution;

g) importation or exportation; and

h) complaints and recalls.

1.3
This Standard is intended to serve as a benchmark and provide minimum requirements for the verification of safe practices in each of the activities listed in Items a) to h) in Clause 1.2.

Note: Examples of establishments or individuals include the following:

a) organ donation organizations;

b) tissue retrieval organizations;

c) tissue banks;

d) eye banks;

e) cell or tissue processing facilities;

f) cell culture laboratories;

g) histocompatibility laboratories;

h) transplant programs and facilities (e.g., hospitals and special clinics);

i) programs for lymphohematopoietic cells, including clinical programs, collection and processing facilities;

j) health care professionals;

k) designated importers and exporters;

l) distributors; and

m) other cell-, tissue-, and organ-dispensing services.

1.4
This Standard and its subset Standards (i.e., the CAN/CSA-Z900 series) are not intended to replace detailed specifications and standard operating procedures, but are intended to be used in their preparation.

1.5
This Standard applies to human cells, tissues, and organs retrieved from a living or deceased human body and intended for transplantation into humans. The requirements for cells and tissues in this Standard are intended for minimally manipulated cells and tissues intended for homologous use (i.e., the cells or tissues perform the same basic function after transplantation).

Notes:

1) Although the scope of this Standard refers to minimally manipulated cells and tissues, some of its requirements can also be relevant to other human cellular and tissue-based products.

2) It is recognized that the topics covered by this Standard can fall within more than one regulatory jurisdiction. Two specific topics covered by this Standard that are not within the current scope of Health Canadaís Safety of Human Cells, Tissues and Organs for Transplantation Regulations are

    a) tissues such as heart valves and dura mater, which are classified by Health Canada as a medical device and are subject to the requirements of the Medical Devices Regulations. Users seeking to market heart valves will require a medical device license; and

    b) autologous tissue banking.
1.6
This Standard does not apply to

a) tissues for assisted reproduction (see CAN/CSA-Z900.2.1);

b) human milk and other excreted or secreted substances;

c) whole blood (except for cord blood), blood components, or blood products; and

d) fecal transplantation.

Notes:

1) For blood components (i.e., red blood cells, granulocytes, platelets, plasma, and cryoprecipitate) and blood products (i.e., therapeutic products derived from plasma), see CAN/CSA-Z902.).

2) CAN/CSA-Z900.2.5 includes specific requirements for cord blood.

1.7
Subset standards have been developed for cells, tissues, and organs (see Clause 2). Where an applicable subset standard exists, this Standard is to be used in conjunction with that subset standard.

Note: Where a subset standard exists and its requirements differ from this Standardís requirements, the subset standardís requirements apply.

1.8
In this Standard, "shall" is used to express a requirement, i.e., a provision that the user is obliged to satisfy in order to comply with the Standard; "should" is used to express a recommendation or that which is advised but not required; and "may" is used to express an option or that which is permissible within the limits of the Standard.

Notes accompanying clauses do not include requirements or alternative requirements; the purpose of a note accompanying a clause is to separate from the text explanatory or informative material.

Notes to tables and figures are considered part of the table or figure and may be written as requirements.

Annexes are designated normative (mandatory) or informative (non-mandatory) to define their application.

Publication type

Print Page

Tell a Friend

GST REG No R119441681
QST REG No R1006017360